Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/04/2003WO2003020901A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2003020900A3 Compositions and methods relating to breast specific genes and proteins
12/04/2003WO2003018798A3 G-protein coupled receptor and dna sequences thereof
12/04/2003WO2003017918A3 A method of inducing the formation of neurofibrillary tangles in transgenic animals
12/04/2003WO2003016491A3 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
12/04/2003WO2003014152A3 Phosphatidylinositol 5-phosphate-binding proteins
12/04/2003WO2003012120A3 Lp354 mammalian secreted protein
12/04/2003WO2003008579A3 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby
12/04/2003WO2003008540A3 Abiotic stress responsive polynucleotides and polypeptides
12/04/2003WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof
12/04/2003WO2003006504A3 Allelic variants of gpr50
12/04/2003WO2003004601A3 New assays for preimplantation factor and preimplantation factor peptides
12/04/2003WO2003004531A3 Regulation of human somatostatin receptor-like protein
12/04/2003WO2003002746A3 Perv screening method and use thereof
12/04/2003WO2003002724A3 Proteins, druggable regions of proteins and target analysis for chemistry of therapeutics
12/04/2003WO2003001876A3 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
12/04/2003WO2003000904A3 Identification and characterization of plant genes
12/04/2003WO2003000897A3 Identification and characterization of phosphate transporter genes
12/04/2003WO2002102977A3 Characterization of a membrane estrogen receptor
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002095052A3 Pna probes, probe sets, methods and kits pertaining to the detection of candida
12/04/2003WO2002087507A3 Breast cancer-associated genes and uses thereof
12/04/2003WO2002086144A3 Compositions and methods for recombinational cloning of nucleic acid molecules
12/04/2003WO2002086090A3 Identification of essential genes of aspegillus fumigatus and methods of use
12/04/2003WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/04/2003WO2002081519A9 Ifn-thy fusion protein,dna coding therefore,its preparation and application
12/04/2003WO2002081516A3 Narc10 and narc16, programmed cell death-associated molecules and uses thereof
12/04/2003WO2002081510A3 Proteins, polynucleotides encoding them and methods of using the same
12/04/2003WO2002079471A3 Cholinesterase-anchoring protein, corresponding nucleic acids and their use for preparing medicines
12/04/2003WO2002079383A3 Fizz1 for metabolism regulation
12/04/2003WO2002079382A3 B-ephrin regulation of g-protein coupled chemoattraction; compositions and methods of use
12/04/2003WO2002077229A3 Cofactors of the liver x receptor alpha and methods of use
12/04/2003WO2002074986A3 An early pre-symptomatic prion diagnostic blood test for encephalopathies
12/04/2003WO2002074344A3 Peg-conjugates of hgt-nk4
12/04/2003WO2002074193A3 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
12/04/2003WO2002070708A3 Glutamate receptor modulatory proteins and nucleic acids encoding them
12/04/2003WO2002069840A3 Nucleic acids for transforming fish cells and methods for their use
12/04/2003WO2002064827A3 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof
12/04/2003WO2002064777A3 Proteins 7b6 and 11b4 and dna sequences encoding the same
12/04/2003WO2002064742A3 Compounds effecting neuron remodeling and assays for same
12/04/2003WO2002062839A3 Markers of unstable atherosclerotic plaques
12/04/2003WO2002057427A3 Mammalian tumor susceptibility gene products and their uses
12/04/2003WO2002039431A3 Compositions and methods relating to prostate specific genes and proteins
12/04/2003WO2002036806A9 Expression vectors able to elicit improved immune response and methods of using same
12/04/2003WO2001072771A3 Insulin and igf-1 receptor agonists and antagonists
12/04/2003WO2001050829A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor
12/04/2003WO1999013818A3 Membrane virus host range mutations and their uses as vaccine substrates
12/04/2003US20030226178 Maize CLAVATA3-like polynucleotide sequences and methods of use
12/04/2003US20030226175 Comprises nucleotide sequences coding polypeptides which control fruit ripening in bananas; bioreactors for expressing heterologous therapeutic proteins
12/04/2003US20030226174 Invention provides transgenic tomato that over-expresses ANT1 and that produces glycitein flavonoid
12/04/2003US20030226173 Transgenic plants expressing heterologous nuclelotide sequences which confer improvement in preferred phenotypic characteristics such as crop yield and/or vigor
12/04/2003US20030226172 Preparing and recovering transgenic and disease resistant grapevines; biological pest control; immunoassay
12/04/2003US20030226171 Insect resistant plants and methods for making same
12/04/2003US20030226170 Transgenic plant comprising vector coding p.parasitica protein (PPR1) protein for propagating disease resistant plants; biological pest control
12/04/2003US20030226169 DNA sequences encoding antifungal proteins
12/04/2003US20030226167 Comprises nucleotide sequences coding maize non-apical meristem protein (ZMNAM) for improving endosperm, kernal size and plant vigor
12/04/2003US20030226159 Preparation of transgenic animal model for monitoring tumor development and treatments using stem cells
12/04/2003US20030226158 Cds1 knockout cells and mice, and their utilization
12/04/2003US20030226156 Obtaining and identifying drosophila neurodegeneration mutant which demonstrates temperature-sensitive and bang-sensitive paralysis phenotypes; neuroprotectants
12/04/2003US20030226155 Modified transferrin-antibody fusion proteins
12/04/2003US20030226154 Pathophysiology associated with a single gene (MASS 1) mutation underlying the robust audiogenic seizure phenotype in frings mice
12/04/2003US20030225253 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030225251 Specificity exchangers that redirect antibodies to a pathogen
12/04/2003US20030225250 Intestinal trefoil proteins
12/04/2003US20030225249 32-kDa protein derived from mycobacterium tuberculosis and related peptides
12/04/2003US20030225246 Novel human 7TM proteins and polynucleotides encoding the same
12/04/2003US20030225025 MDA-7 proteins and methods of use thereof
12/04/2003US20030225023 Gene SHINC-2 and diagnostic and therapeutic uses thereof
12/04/2003US20030225021 Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
12/04/2003US20030225018 Modulating angiogenesis in an animal by modulating the expression or activity of syndecan-2.
12/04/2003US20030225017 Chlamydia antigens and corresponding DNA fragments and uses thereof
12/04/2003US20030225009 28 human secreted proteins
12/04/2003US20030225008 Diagnosis of abnormal cellular proliferation by examining or monitoring cells for perturbations in H37 expression; treatment by inserting into H37 protein into a host cell
12/04/2003US20030224997 Synthetic peptide whose amino acid sequence is different from an initial loop of cobra cardiotoxin; also treating HIV-1 infection or autoimmune diseases
12/04/2003US20030224996 Comprising a matrix containing pure natural-sourced mammalian osteogenic protein
12/04/2003US20030224993 Compositions that inhibit proliferation of cancer cells
12/04/2003US20030224992 Transcription control recognition sequence for a transcription factor coupled to a membrane permeable peptidic sequence, that facilitates the delivery of said recognition sequence to a nucleus of a cell.
12/04/2003US20030224991 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
12/04/2003US20030224990 IGF-binding protein-derived peptide or small molecule
12/04/2003US20030224986 Method of treating apoptosis and compositions thereof
12/04/2003US20030224984 Treating trauma such as wounds, various cancers, and disorders of the vessels including atherosclerosis and cardiac hypertrophy.
12/04/2003US20030224983 Stimulation of beta cell proliferation
12/04/2003US20030224982 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/04/2003US20030224981 Administering a protein comprising at least one binding domain for a laminin and at least one binding domain for alpha-dystroglycan or a nucleic acid encoding the protein
12/04/2003US20030224980 Diagnostic reagents for human cytomegalovirus and methods of use
12/04/2003US20030224979 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
12/04/2003US20030224978 Compounds and methods for modulating apoptosis
12/04/2003US20030224976 Compositions, methods and kits relating to behab and primary CNS tumors
12/04/2003US20030224973 Minimising body gain in insulin treatment
12/04/2003US20030224972 Inhibiting melanin production by melanocytes.
12/04/2003US20030224968 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin
12/04/2003US20030224509 DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer
12/04/2003US20030224508 Novel vectors and genes exhibiting increased expression
12/04/2003US20030224498 Comprises nucleotide sequences coding serpin domains for diagnosis and treatment of metabolic and infectious disorders; enzyme inhibitors; cosmetic or nutriceutical; drug screening
12/04/2003US20030224490 Fusion partner cells and uses thereof
12/04/2003US20030224488 Materials and methods for preparing dimeric growth factors
12/04/2003US20030224487 Novel cytokine zcytor17 ligand
12/04/2003US20030224486 Polynucleotides and polypeptides associated with the NF-kB pathway
12/04/2003US20030224485 Comprises nucleotide sequences for transcription and translation of functional ATP binding cassette transport protein (ABCR) for use in gene therapy
12/04/2003US20030224478 Secreted and transmembrane polypeptides and nucleic acids encoding the same
1 ... 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 ... 2916